TITLE

Understanding the Effects of Hormonal Contraception on HIV Transmission

AUTHOR(S)
McEnery, Regina
PUB. DATE
November 2011
SOURCE
VAX;Nov2011, Vol. 9 Issue 6, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the risks and benefits of using hormonal contraception in HIV prevention trials. It indicates that the mechanism of how hormonal contraception increased the risk of HIV infection is not clear. It suggests the importance of identifying the mechanisms that accelerate or block viral entry in the vaginal mucosa to study HIV pathogenesis and prevention.
ACCESSION #
71847937

 

Related Articles

  • Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa. Lazarus, Erica Maxine; Otwombe, Kennedy; Adonis, Tania; Sebastian, Elaine; Gray, Glenda; Grunenberg, Nicole; Roux, Surita; Churchyard, Gavin; Innes, Craig; Laher, Fatima // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    : Because sexual transmission of HIV occurs across mucosal membranes, understanding the immune responses of the genital mucosa to vaccines may contribute knowledge to finding an effective candidate HIV vaccine. We describe the uptake of rectal secretion, cervical secretion and seminal mucosal...

  • Seeking Effective Topical Microbicides. Greenberger, Phyllis // Journal of Women's Health & Gender-Based Medicine;Mar2001, Vol. 10 Issue 2, p99 

    This article discusses the women's health and hygiene. There are a number of microbicides in development, with mechanisms of action that include pathogen membrane disruption, vaginal defense enhancement acid pH buffering, and inhibition of retroviral binding and attachment. Various natural...

  • Future Prospects and Perspectives on Microbicides. Anton, Peter A. // Current HIV Research;Jan2012, Vol. 10 Issue 1, p113 

    As 'proof of concept' has now been well validated for topical microbicides, the progress has, appropriately, refined the questions of who, how, when and at what risk and cost. These are welcome challenges requiring intensified, cross-disciplinary responses. This is especially true in the areas...

  • Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception? Ssali, Agnes; Namukwaya, Stella; Bufumbo, Leonard; Seeley, Janet; G. Lalloo, David; Kamali, Anatoli; Parkes-Ratanshi, Rosalind // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Objective: Higher than expected pregnancy rates have been observed in HIV related clinical trials in Sub-Saharan Africa. We designed a qualitative study to explore the factors contributing to high pregnancy rates among participants in two HIV clinical trials in Sub-Saharan Africa. Methods:...

  • Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission. Smedley, Jeremy; Turkbey, Baris; Bernardo, Marcelino L.; Del Prete, Gregory Q.; Estes, Jacob D.; Griffiths, Gary L.; Kobayashi, Hisataka; Choyke, Peter L.; Lifson, Jeffrey D.; Keele, Brandon F. // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Over 80% of sexual HIV-1 transmissions originate from a single viral variant, but the underlying basis for this transmission bottleneck remains to be elucidated. Nonhuman primate models of mucosal virus transmission allow opportunities to gain insight into the basis of this mucosal bottleneck....

  • Mucosal gatekeepers: Selecting HIV viruses for early infection. Bomsel, Morgane; David, Violaine // Nature Medicine;Feb2002, Vol. 8 Issue 2, p114 

    Focuses on a study that shows that mucosal cells are the principal portal of HIV-1 entry. Description of a new model system by researchers Smith and colleagues to study the initial events of HIV-1 entry in monostratified epithelium; Occurrence of a selection process at the site of the HIV-1 entry.

  • Transmission of HIV possibly associated with exposure of mucous membrane to contaminated blood.  // JAMA: Journal of the American Medical Association;08/20/97, Vol. 278 Issue 7, p539 

    Summarizes an investigation into the case of a woman who may have become infected with the human immunodeficiency virus (HIV) through exposure of a mucous membrane to contaminated blood. Sexual activity of woman with HIV infected partner; Dental problems of both; Onset of symptoms in woman;...

  • Innate Immunity and HIV-1 Infection. Lehner, T.; Wang, Y.; Whittall, T.; Seidl, T. // Advances in Dental Research;Apr2011, Vol. 23 Issue 1, p19 

    HIV-1 is predominantly transmitted through mucosal tissues, targeting CD4+CCR5+ T cells, 50% of which are destroyed within 2 weeks of infection. Conventional vaccination strategies have so far failed to prevent HIV-1 infection. Neither antibodies nor cytotoxic lymphocytes are capable of mounting...

  • An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings. MacQueen, Kathleen M.; Tolley, Elizabeth E.; Owen, Derek H.; Rivet Amico, K.; Morrow, Kathleen M.; Moench, Thomas; Friend, David R.; Friedland, Barbara // Journal of the International AIDS Society;2014 Supplement 2, Vol. 17 Issue Supp 2, p1 

    Introduction: Product adherence and its measurement have emerged as a critical challenge in the evaluation of new HIV prevention technologies. Long-acting ARV-based vaginal rings may simplify use instructions and require less user behaviour, thereby facilitating adherence. One ARV-based ring is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics